Brownlie Keith L 4
4 · Celldex Therapeutics, Inc. · Filed Jun 19, 2020
Insider Transaction Report
Form 4
Brownlie Keith L
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2020-06-18+11,000→ 11,000 totalExercise: $10.38From: 2021-06-18Exp: 2030-06-18→ Common Stock (11,000 underlying)
Footnotes (1)
- [F1]Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.